Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Successful mobilisation of peripheral blood stem cells in children using plerixafor: a case report and review of the literature.

× No keyword cloud information.

11 in total

1. The use of plerixafor in harvesting autologous stem cells in the pediatric setting.

Authors: Kim Vettenranta; Merja Möttönen; Pekka Riikonen
Journal: Pediatr Blood Cancer Date: 2011-10-19 Impact factor: 3.167

2. Priming of hematopoietic progenitor cells by plerixafor and filgrastim in children with previous failure of mobilization with chemotherapy and/or cytokine treatment.

Authors: Julián Sevilla; Elisabetta Schiavello; Luis Madero; Manuela Pardeo; Elena Guggiari; Marta Baragaño; Roberto Luksch; Maura Massimino
Journal: J Pediatr Hematol Oncol Date: 2012-03 Impact factor: 1.289

3. The feasibility of plerixafor as a second-line stem cell mobilizing agent in children.

Authors: Kanakkande Aabideen; Parameswaran Anoop; Mark E Ethell; Mike N Potter
Journal: J Pediatr Hematol Oncol Date: 2011-01 Impact factor: 1.289

4. Successful mobilization, harvest and transplant of peripheral blood stem cells using AMD3100 and G-CSF following high dose craniospinal irradiation for medulloblastoma in a young child.

Authors: Helen Toledano; Anat Yahel; Ian J Cohen; Isaac Yaniv; Jerry Stein
Journal: Pediatr Blood Cancer Date: 2010-04 Impact factor: 3.167

5. Plerixafor added to chemotherapy plus G-CSF is safe and allows adequate PBSC collection in predicted poor mobilizer patients with multiple myeloma or lymphoma.

Authors: Immacolata Attolico; Vincenzo Pavone; Angelo Ostuni; Bernardo Rossini; Maurizio Musso; Alessandra Crescimanno; Massimo Martino; Pasquale Iacopino; Giuseppe Milone; Patrizia Tedeschi; Sabrina Coluzzi; Roberta Nuccorini; Sara Pascale; Elvira Di Nardo; Attilio Olivieri
Journal: Biol Blood Marrow Transplant Date: 2011-07-24 Impact factor: 5.742

6. A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma.

Authors: Amanda Cashen; Sandra Lopez; Feng Gao; Gary Calandra; Ron MacFarland; Karin Badel; John DiPersio
Journal: Biol Blood Marrow Transplant Date: 2008-11 Impact factor: 5.742

7. Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma.

Authors: John F DiPersio; Edward A Stadtmauer; Auayporn Nademanee; Ivana N M Micallef; Patrick J Stiff; Jonathan L Kaufman; Richard T Maziarz; Chitra Hosing; Stefan Früehauf; Mitchell Horwitz; Dennis Cooper; Gary Bridger; Gary Calandra
Journal: Blood Date: 2009-04-10 Impact factor: 22.113

8. Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma.

Authors: John F DiPersio; Ivana N Micallef; Patrick J Stiff; Brian J Bolwell; Richard T Maziarz; Eric Jacobsen; Auayporn Nademanee; John McCarty; Gary Bridger; Gary Calandra
Journal: J Clin Oncol Date: 2009-08-31 Impact factor: 44.544

9. Successful mobilization of peripheral blood stem cells in children with cancer using plerixafor (Mozobil) and granulocyte-colony stimulating factor.

Authors: Boryana E Avramova; Maya N Yordanova; Dobrin N Konstantinov; Dragan G Bobev
Journal: Drug Des Devel Ther Date: 2011-08-26 Impact factor: 4.162

10. Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo.

Authors: A Olivieri; M Marchetti; R Lemoli; C Tarella; A Iacone; F Lanza; A Rambaldi; A Bosi
Journal: Bone Marrow Transplant Date: 2011-05-30 Impact factor: 5.483